期刊文献+

氯沙坦对高糖培养的人系膜细胞血管内皮细胞生长因子表达的影响 被引量:2

Effect of losartan on expression of human endothelial vascular growth factor mRNA of cultured human mesangial cells in high glucose
下载PDF
导出
摘要 目的:探讨氯沙坦对高糖培养的系膜细胞产生活性氧和血管内皮细胞生长因子(VEGF)mRNA表达的影响。方法:体外培养人系膜细胞,用高糖、氯沙坦干预不同时间后,应用比色法检测培养细胞上清液中超氧化物歧化酶(SOD)、过氧化氢酶(CAT)的活力,丙二醛(MDA)的水平。用RT鄄PCR法测定血管内皮细胞生长因子(VEGF)mRNA表达的影响。结果:与正常对照组相比,高糖组SOD、CAT的活力明显降低,而MDA含量明显升高,VEGFmRNA表达升高。与高糖组相比,高糖加氯沙坦组的SOD、CAT的活力升高,MDA水平下降,VEGFmRNA表达上调。结论:氯沙坦能抑制高糖所致细胞活性氧的产生和VEGF的表达,从而抑制细胞通透性升高,降低蛋白尿,发挥其肾保护作用。 Objective: To investigate the effect of Losartan on the production of reactive oxygen species(ROS) and the expression of endothelial vascular growth factor(VEGF) in human mesangial cells cultured in high glucose. Methods:Human mesangial cells were cultured in high glucose with or without Losartan, the activities of SOD and CAT, the level of MDA in the supernatant were measured by spectrophotometry and the expression of VEGF mRNA in the cells were measured by RT-PCR. Results:Compared with the control group, the activities of SOD and CAT were markedly lower, while the level of MDA was greatly higher in the high glucose group. High glucose stimulated the expression of VEGF mRNA. Compared with the high glucose group, high glucose with Losartan heightened the activities of SOD and CAT, declined the level of MDA, and down-regulated the expression of VEGF mRNA. Conclusion:Losartan might inhibit the production of ROS and down-regulate the expression of VEGF mRNA induced by high glucose. Thus the celluar permeability was suppressed, and the proteinuria was reduced. This maybe another mechanism which protects renal function from diabetic nephropathy .
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第3期150-153,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助项目(30370658)
关键词 氯沙坦 系膜细胞 活性氧 血管内皮细胞生长因子 Losartan mesangial cell reactive oxygen species vascular endothelial growth factor
  • 相关文献

参考文献24

  • 1Ha H, Kim KH. Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C[J]. Diabetes Res Clin Pract, 1999,45(2-3):147-151. 被引量:1
  • 2Koyama S, Sato E, Tsukadaira A, et al. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro [J]. Eur Respir J,2002,20 (6): 1449-1456. 被引量:1
  • 3Ha H, Yu MR, Choi Y J, et al. Role of high glucoseinduced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells[J]. J Am Soc Nephrol,2002,13(4):894-902. 被引量:1
  • 4Cooper ME, Vranes D, Youssef S, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 and in experimental diabetes[J]. Diabetes, 1999,48:2229-2239. 被引量:1
  • 5Cha DR, Kim NH, Yoon JW, et al. Role of vascular endothelial growth factor in diabetic nephropathy [J].Kidney Iht Suppl, 2000,77: S 104-112. 被引量:1
  • 6Kim NH, Jung HH, Cha DR, et al. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells [J]. J Endocrinol,2000,165(3) :617-624. 被引量:1
  • 7Kedziora-Kornatowska K. Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats[J]. Clin Chim Acta, 1999,287(1-2) :19-27. 被引量:1
  • 8Seshiah PN, Weber DS, Rocic P, et al. Angiotensin Ⅱ stimulation of NAD (P) H oxidase activity:upstream mediators[J]. Circ Res,2002,91 (5) :406-413. 被引量:1
  • 9Inoguchi T, Sonta T, Tsubouchi H, et al.Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD (P) H oxidase [J]. J Am So Nephrol,2003,14, (8Suppl 3): S 227-232. 被引量:1
  • 10Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by angiotensin Ⅱ in rat heart endothelial cells [J]. Biochim Biophys Acta,1998,1401(2): 187-194. 被引量:1

同被引文献12

  • 1邝国平,姜德咏,郭丽花,万华.糖基化终产物促人视网膜色素上皮细胞表达VEGFmRNA[J].眼科新进展,2005,25(1):37-40. 被引量:4
  • 2赵龙,邓红,汪颖南,苏宁,刘必成,刘东风.高糖、茶多酚对人系膜细胞结缔组织生长因子、纤维连接蛋白mRNA表达的影响[J].南京医科大学学报(自然科学版),2005,25(3):157-160. 被引量:5
  • 3Li-jun YAO,Jian-qing WANG,Hong ZHAO,Jian-she LIU,An-guo DENG.Effect of telmisartan on expression of protein kinase C-α in kidneys of diabetic mice[J].Acta Pharmacologica Sinica,2007,28(6):829-838. 被引量:8
  • 4YOUNG Y W,KWON H M,HWANG K C,et al.Upstream regulation of matrix metalloproteinase by EMMPRIN:extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque[J].Atherosclerosis,2005,180(1):37-44. 被引量:1
  • 5SONG Y,LI C,CAI L.Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation[J].Exper Molec Pathol,2004,76(1):66-75. 被引量:1
  • 6GUO H,ZUCKER S,GORDON M K,et al.Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells[J].J Biol Chem,1997,272 (1):24-27. 被引量:1
  • 7SUZUKI S,SATO M,SENOO H,et al.Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts:involvement of EMMPRIN and MT1-MMP[J].Exper Cell Res,2004,293 (2):259-266. 被引量:1
  • 8ELLIS S M,NABESHIMA K,BISWAS C.Monoclonal antibody preparation and purification of a tumor cell collagenase stimulatory factor[J].Cancer Res,1989,49(12):3385-3391. 被引量:1
  • 9BISWAS C,ZHANG Y,DECASTRO R,et al.The human tumor cell-drived collagenase stimulatory factor(renamed EMMPRIN) is a member of the immunoglobulin superfamily[J].Cancer Res,1995,55 (2):434-439. 被引量:1
  • 10PORTIK-DOBOS V,ANSTADT M P,HUTCHINSON J,et al.Evidence for a matrix metallo-proteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes[J].Diabetes,2002,51 (10):3063-3068. 被引量:1

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部